Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
Details for Australian Patent Application No. 2003244646 (hide)
International Classifications
Event Publications
25 September 2003 Complete Application Filed
Priority application(s): 60/380,850 17.05.02 US
29 January 2004 Application Open to Public Inspection
Published as AU-B-2003244646
7 August 2008 Application Accepted
Published as AU-B-2003244646
4 December 2008 Standard Patent Sealed
16 September 2010 Licence Registered
Aventis Pharma S.A. ( sanofi-aventis Australia Pty Ltd )
3 February 2011 Licence Registered
Aventis Pharma S.A. ( May & Baker Limited )
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser